Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) has soared vigorously in today’s market scenario, registering a notable ascension of 279.06% and reaching $1.28 today as per the
On January 27, Zynerba Pharmaceuticals Inc. (ZYNE) stock suffered a further loss of 5.83% in the pre-market. There has been no recent announcement from the
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.